Financial reports
10-Q
2023 Q3
Quarterly report
2 Jan 24
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-K/A
2021 FY
Annual report (amended)
15 Jul 22
Current reports
8-K
Entry into a Material Definitive Agreement
15 Mar 24
8-K
Material Modifications to Rights of Security Holders
26 Feb 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Regulation FD Disclosure
12 Feb 24
8-K
Entry into a Material Definitive Agreement
17 Jan 24
8-K
Celularity Announces Net Sales and Total Revenue Expectations
9 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 Nov 23
8-K
Entry into a Material Definitive Agreement
19 Sep 23
8-K
Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors
7 Sep 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
28 Jul 23
424B3
Prospectus supplement
2 Jun 23
S-3
Shelf registration
25 May 23
424B5
Prospectus supplement for primary offering
6 Apr 23
424B5
Prospectus supplement for primary offering
15 Sep 22
424B5
Prospectus supplement for primary offering
8 Sep 22
424B3
Prospectus supplement
24 Aug 22
424B3
Prospectus supplement
24 Aug 22
S-3
Shelf registration
11 Aug 22
POS AM
Prospectus update (post-effective amendment)
11 Aug 22
Proxies
DEF 14A
Definitive proxy
2 Feb 24
PRE 14A
Preliminary proxy
23 Jan 24
DEF 14A
Definitive proxy
1 May 23
PRE 14A
Preliminary proxy
21 Apr 23
DEF 14A
Definitive proxy
3 Jun 22
DEFA14A
Additional proxy soliciting materials
10 May 21
DEFA14A
Additional proxy soliciting materials
16 Apr 21
DEF 14A
Definitive proxy
14 Apr 21
PRE 14A
Preliminary proxy
29 Mar 21
DEF 14A
Definitive proxy
4 Dec 20
Other
EFFECT
Notice of effectiveness
5 Jun 23
CORRESP
Correspondence with SEC
31 May 23
UPLOAD
Letter from SEC
31 May 23
EFFECT
Notice of effectiveness
24 Aug 22
EFFECT
Notice of effectiveness
24 Aug 22
EFFECT
Notice of effectiveness
19 Aug 22
CORRESP
Correspondence with SEC
16 Aug 22
UPLOAD
Letter from SEC
16 Aug 22
EFFECT
Notice of effectiveness
1 Jun 22
CORRESP
Correspondence with SEC
27 May 22